Literature DB >> 25635120

Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease.

Robert L Colebunders1, Robert O Cannon2.   

Abstract

Entities:  

Keywords:  Ebola virus disease; blood transfusions; plasma transfusion; treatment

Mesh：

Year:  2015        PMID： 25635120     DOI： 10.1093/infdis/jiv043

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

2.  A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.

Authors:  Scott M Berry; Elizabeth A Petzold; Peter Dull; Nathan M Thielman; Coleen K Cunningham; G Ralph Corey; Micah T McClain; David L Hoover; James Russell; J McLeod Griffiss; Christopher W Woods
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

3.  Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.

Authors:  Alexandre Delamou; Nyankoye Yves Haba; Almudena Mari-Saez; Pierre Gallian; Maya Ronse; Jan Jacobs; Bienvenu Salim Camara; Kadio Jean-Jacques Olivier Kadio; Achille Guemou; Jean Pe Kolie; Maaike De Crop; Patricia Chavarin; Chantal Jacquot; Catherine Lazaygues; Anja De Weggheleire; Lutgarde Lynen; Johan van Griensven
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

4.  Effect and clinical value of coagulation test on adverse reactions of blood transfusion in patients with major bleeding in ectopic pregnancy.

Authors:  Fanjiu Kong; Yingbo Li; Xiaoxin Liu
Journal:  Exp Ther Med       Date:  2018-09-27       Impact factor: 2.447

Review 5.  The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease.

Authors:  Scott A Koepsell; Anne M Winkler; John D Roback
Journal:  Transfus Med Rev       Date:  2016-11-16

6.  Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.

Authors:  Alfredo Mendrone-Junior; Carla Luana Dinardo; Suzete Cleuza Ferreira; Anna Nishya; Nanci Alves Salles; Cesar de Almeida Neto; Debora Toshei Hamasaki; Tila Facincani; Lucas Bassolli de Oliveira Alves; Rafael Rahal Guaragna Machado; Danielle Bastos Araujo; Edison Luiz Durigon; Vanderson Rocha; Ester Cerdeira Sabino
Journal:  Transfusion       Date:  2021-01-25       Impact factor: 3.337

7.  Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.

Authors:  Tansy Edwards; Malcolm G Semple; Anja De Weggheleire; Yves Claeys; Maaike De Crop; Joris Menten; Raffaella Ravinetto; Sarah Temmerman; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Johan van Griensven
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

8.  Ebola Virus Infection: Overview and Update on Prevention and Treatment.

Authors:  Miguel J Martínez; Abdulbaset M Salim; Juan C Hurtado; Paul E Kilgore
Journal:  Infect Dis Ther       Date:  2015-09-12

Review 9.  Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Authors:  O Garraud; F Heshmati; B Pozzetto; F Lefrere; R Girot; A Saillol; S Laperche
Journal:  Transfus Clin Biol       Date:  2016-01-06       Impact factor: 1.406

10.  The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.

Authors:  Johan van Griensven; Anja De Weiggheleire; Alexandre Delamou; Peter G Smith; Tansy Edwards; Philippe Vandekerckhove; Elhadj Ibrahima Bah; Robert Colebunders; Isola Herve; Catherine Lazaygues; Nyankoye Haba; Lutgarde Lynen
Journal:  Clin Infect Dis       Date:  2015-08-10       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.